360Dx

UMass

Oct 06, 2020

BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization

BioFire's test is designed to detect and differentiate between SARS-CoV-2 and other respiratory pathogens, while UMass Medical's test is only for SARS-CoV-2.

Menu

UMass

BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization

Breaking News

In Brief This Week: Quest Diagnostics, Fluidigm, BD, and More

Tempus Gets CE Mark for xT Tumor Sequencing Assay

BTIG Downgrades Fulgent Genetics from Buy to Neutral

Cepheid Receives CE Mark for SARS-CoV-2, Flu A/B, RSV Combination Test

OpGen Inks $10M Private Placement Agreement

Agilent Q4 Revenues Rise 8 Percent